With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced ...

The current market presents a complex mix of opportunities and risks. Check out my picks that include high-quality, ...

Researchers explain how a drug that helps patients with neurological issues walk may also provide a surprising boost for the ...

Her stark warning comes as Fianna Fáil tries to row back from its manifesto pledge to legalise drugs for personal use.

Legislators will consider a new law allowing Wyoming judges to issue permanent, lifetime protection orders. Victims of sex assault, stalking and ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

The Food and Drug Administration approved on Friday a new drug developed by Syndax Pharmaceuticals to treat patients with a ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...